Category: Psychedelic Policy & Science

Canada stands at the forefront of a global shift in mental healthcare and psychedelic drug reform. A pivotal catalyst in this movement is parliamentary legislation championed by Member of Parliament Rachael Thomas. In this regulatory overview, we analyze how the thomas bill psilocybin canada initiative (Private Member’s Bill C-286) seeks to formally amend the Controlled…